Select Medical Holdings Corporation
SEMNYSEHealthcare● Active
$16.59
+$0.05(+0.30%)
Market Cap$2.1B
P/E Ratio—
52W High$16.99
52W Low$11.65
Select Medical Holdings Corporation (SEM) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
SEM · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: Apr 30, 2026EPS Actual
$0.36
Est. $0.43 · -16.3%
Revenue
$1.42B
Est. $1.41B · +0.7%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
Apr 30, 2026
After Market Close
▼ Miss EPS
SEM reports quarterly as a NYSE-listed Medical - Care Facilities company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$0.07
Rev. $15.39B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$0.07
Rev. Est.$15.39B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Jul 30, 2026 | $0.29 | — | — | — | $1.40B | — |
| ▼ Q2 FY2026 | Apr 30, 2026 | $0.43 | $0.36 | -16.3% | $1.42B | $1.41B | +0.7% |
| ▼ Q1 FY2026 | Feb 19, 2026 | $0.23 | $0.16 | -30.4% | $1.40B | $1.36B | +2.4% |
| ▲ Q4 FY2025 | Oct 30, 2025 | $0.18 | $0.23 | +27.8% | $1.36B | $1.36B | -0.1% |
| ▲ Q3 FY2025 | Jul 31, 2025 | $0.28 | $0.32 | +14.3% | $1.34B | $1.33B | +0.4% |
| ▼ Q2 FY2025 | May 1, 2025 | $0.45 | $0.44 | -2.2% | $1.35B | $1.40B | -3.0% |
| ▼ Q1 FY2025 | Feb 20, 2025 | $0.29 | $0.18 | -37.9% | $1.23B | $1.50B | -18.4% |
| — Q4 FY2024 | Oct 31, 2024 | $0.43 | $0.43 | +0.0% | $1.76B | $1.74B | +1.1% |
Q3 FY2026
Jul 30, 2026
EPS Actual
—
EPS Est.
$0.29
EPS Surpr.
—
Revenue
—
Q2 FY2026
Apr 30, 2026Miss
EPS Actual
$0.36
EPS Est.
$0.43
EPS Surpr.
-16.3%
Revenue
$1.42B
Q1 FY2026
Feb 19, 2026Miss
EPS Actual
$0.16
EPS Est.
$0.23
EPS Surpr.
-30.4%
Revenue
$1.40B
Q4 FY2025
Oct 30, 2025Beat
EPS Actual
$0.23
EPS Est.
$0.18
EPS Surpr.
+27.8%
Revenue
$1.36B
Q3 FY2025
Jul 31, 2025Beat
EPS Actual
$0.32
EPS Est.
$0.28
EPS Surpr.
+14.3%
Revenue
$1.34B
Q2 FY2025
May 1, 2025Miss
EPS Actual
$0.44
EPS Est.
$0.45
EPS Surpr.
-2.2%
Revenue
$1.35B
Q1 FY2025
Feb 20, 2025Miss
EPS Actual
$0.18
EPS Est.
$0.29
EPS Surpr.
-37.9%
Revenue
$1.23B
Q4 FY2024
Oct 31, 2024
EPS Actual
$0.43
EPS Est.
$0.43
EPS Surpr.
+0.0%
Revenue
$1.76B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2028 | $0.27 | $0.27 | $0.27 | 1 |
| Q3 FY2028 | $0.25 | $0.25 | $0.25 | 1 |
| Q2 FY2028 | $0.35 | $0.35 | $0.35 | 1 |
| Q1 FY2028 | $0.49 | $0.50 | $0.50 | 1 |
| Q4 FY2027 | $0.30 | $0.30 | $0.30 | 1 |
| Q3 FY2027 | $0.24 | $0.24 | $0.24 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2028 | $1.6B | $1.6B | $1.6B | 1 |
| Q3 FY2028 | $1.6B | $1.6B | $1.6B | 1 |
| Q2 FY2028 | $1.5B | $1.6B | $1.6B | 1 |
| Q1 FY2028 | $1.5B | $1.6B | $1.6B | 1 |
| Q4 FY2027 | $1.5B | $1.5B | $1.5B | 1 |
| Q3 FY2027 | $1.5B | $1.5B | $1.5B | 2 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▼ Q2 FY2026 | Apr 30, 2026 | -16.3% | $16.49 | $16.41 | -0.49% |
| ▼ Q1 FY2026 | Feb 19, 2026 | -30.4% | $16.32 | $16.08 | -1.47% |
| ▲ Q4 FY2025 | Oct 30, 2025 | +27.8% | $14.28 | $14.20 | -0.56% |
| ▲ Q3 FY2025 | Jul 31, 2025 | +14.3% | $14.48 | $14.79 | +2.14% |
| ▼ Q2 FY2025 | May 1, 2025 | -2.2% | $18.24 | $18.24 | +0.00% |
| ▼ Q1 FY2025 | Feb 20, 2025 | -37.9% | $19.25 | $19.06 | -0.99% |
| ▲ Q4 FY2024 | Oct 31, 2024 | +0.0% | $17.69 | $17.28 | -2.32% |
| ▼ Q3 FY2024 | Aug 1, 2024 | -1.6% | $21.41 | $21.10 | -1.45% |
Q2 FY2026-0.49%
Report Date
Apr 30, 2026
EPS Beat/Miss
-16.3%
Price Before
$16.49
Price After
$16.41
Q1 FY2026-1.47%
Report Date
Feb 19, 2026
EPS Beat/Miss
-30.4%
Price Before
$16.32
Price After
$16.08
Q4 FY2025-0.56%
Report Date
Oct 30, 2025
EPS Beat/Miss
+27.8%
Price Before
$14.28
Price After
$14.20
Q3 FY2025+2.14%
Report Date
Jul 31, 2025
EPS Beat/Miss
+14.3%
Price Before
$14.48
Price After
$14.79
Q2 FY2025+0.00%
Report Date
May 1, 2025
EPS Beat/Miss
-2.2%
Price Before
$18.24
Price After
$18.24
Q1 FY2025-0.99%
Report Date
Feb 20, 2025
EPS Beat/Miss
-37.9%
Price Before
$19.25
Price After
$19.06
Q4 FY2024-2.32%
Report Date
Oct 31, 2024
EPS Beat/Miss
+0.0%
Price Before
$17.69
Price After
$17.28
Q3 FY2024-1.45%
Report Date
Aug 1, 2024
EPS Beat/Miss
-1.6%
Price Before
$21.41
Price After
$21.10
Avg Beat Reaction-0.25%
Avg Miss Reaction-0.88%
Beat Rate3 / 8 quarters
Largest Move-2.32% (Q4 FY2024)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: SEM ends December
Select Medical Holdings Corporation (SEM) most recently reported earnings on April 30, 2026 for Q2 FY2026, posting EPS of $0.36 — missing the analyst consensus of $0.43 by -16.3%. The next SEM earnings date is expected around September 1, 2026.
Each quarter, investors track SEM earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. SEM revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
SEM's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
SEM earnings · 5 questionsSelect Medical Holdings Corporation's next earnings report is expected around September 1, 2026. SEM typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; SEM historically reports after market close (AMC).
SEM earnings datewhen is SEM earningsSEM next earnings datewhen does SEM report earningsSEM earnings calendar
▸ Source: FMP · Select Medical Holdings Corporation SEC filings · US GAAP · Select Medical Holdings Corporation SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026